Shanghai Vitalgen Biopharma Co., Ltd.

Shanghai Vitalgen Biopharma Co., Ltd. company information, Employees & Contact Information

Vitalgen (Series B+, $160M total funding), founded in 2020 in Shanghai, specializes in pioneering gene delivery and gene editing technologies to address ophthalmologic and neurodegenerative diseases, including Bietti Crystalline Dystrophy (BCD) and Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) in Phase III, as well as Parkinson’s Disease (PD) and Glutaric Acidemia Type 1 (GA-1) in Phase I/II. The company has developed three globally innovative and proprietary platforms: ViCas® – CRISPR-Cas12b gene editing ViLNP® – Lipid nanoparticle technology ViVec® – AAV new serotype vector screening Beyond these core programs, Vitalgen is also advancing preclinical-stage therapies for Alzheimer’s Disease (AD) and Amyotrophic Lateral Sclerosis (ALS, IIT ongoing) using AAV-based approaches, as well as Type 1 Diabetes (T1D) and Epilepsy through cell therapy (ESC).

Company Details

Employees
9
Founded
-
Address
Building 2, No. 11, Galileo Road, Zhangjiang, Pu Dong, Shanghai,shanghai 201210,china
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Shanghai, Shanghai
Looking for a particular Shanghai Vitalgen Biopharma Co., Ltd. employee's phone or email?

Shanghai Vitalgen Biopharma Co., Ltd. Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant